Insights on the Indian Cancer Biomarker Market to 2019 | Industry Statistics, Emerging Demands, Forecast to 2025
Indian cancer biomarker market is expected to grow at a CAGR of around 12.0% during the forecast period. India is a strong market for cancer biomarkers particularly due to its large population base and large mortality due to cancer. Global cancer biomarker market has huge scope in India as biomarker development will enable in screening of large populations. It may depend on the specific use of a cancer biomarker. Earlier diagnosis of cancer through biomarkers will result in the reduction of financial stress over the population and government, minimizing the cost of adverse events. The fast and speedy diagnosis of cancer in country such as India with a population of 1.31 billion is required which can be achieved with biomarker development in the region. Further biomarker applications in diagnosis, monitoring of effects during treatment and surveillance of patients during or following treatment as well as treatment optimization will spur the growth of the market in this region.
To Request a Sample of our Report on Peptide
and Anticoagulant Drug Market: https://www.omrglobal.com/request-sample/indian-cancer-biomarker-market
There are many Indian companies in
the Indian cancer biomarker that are striving to contribute significantly in
the landscape. The companies are collaborating with many foreign companies for
promoting biomarker and personalized medicine approach for treating cancer.
Core Diagnostics, Nutech Cancer Biomarkers, Cancer Genetics, Biogenuix,
BioServe Biotechnologies are contributing in the cancer biomarker market in
India. In April 2017, Core Diagnostics partnered with a silicon-based life
science company called CellMax Life. The objective was to introduce CellMax
Life’s genetic cancer risk test and ctDNA-based liquid biopsy in Indian markets
for faster diagnosis and cancer treatment. These diagnostic advancements are
capable of reducing cancer mortality of India by offering personalized,
precision cancer risk assessment and screening. Thus, such initiatives and
activities by the companies led to the growth of the Indian cancer biomarker.
(Get 15% Discount on Buying this Report)
A
full Report of Indian Cancer Biomarker Market is Available @ https://www.omrglobal.com/industry-reports/indian-cancer-biomarker-market
Cancer Biomarker Market Segmentation
By Biomarker Type
·
Genetic Biomarker
·
Protein Biomarker
By Cancer Type
·
Lung Cancer
·
Prostate Cancer
·
Breast Cancer
·
Colorectal Cancer
·
Cervical Cancer
·
Other
By Applications
·
Drug Discovery and Development
·
Diagnosis
·
Risk Assessment
·
Prognostics
By Profiling Technology
·
Omics Technology
·
Immunoassays
·
Cytogenetics
·
Bioinformatics
Company Profiles
·
Abbott laboratories Inc.
·
Astellas Pharma Inc.
·
Becton, Dickson and Co.
·
Bio-Rad Laboratories, Inc.
·
Danaher Corp.
·
F. Hoffmann-La Roche Ltd.
·
Merck and Co., Inc.
·
Novartis AG
·
Pfizer Inc.
·
QIAGEN GmbH
·
Thermo Fisher Scientific Inc.
Reasons to buy from us
–
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment